Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | FAH |
| Upstream (Parents) |
|---|
| (<<) APOM → FAH |
| Downstream (Children) |
|---|
| FAH → SULT1A2 (>>) |
| FAH → CFP (>>) |
| FAH → LASS4 (>>) |
| FAH → SLC17A1 (>>) |
| FAH → ADRA1B (>>) |
| FAH → CYP11A1 (>>) |
| FAH → CYP27A1 (>>) |
| FAH → PRDM12 (>>) |
| FAH → GGT1 (>>) |
| FAH → SLC25A20 (>>) |
| FAH → ETFB (>>) |
| FAH → MYL10 (>>) |
| FAH → FAM50B (>>) |
| FAH → AIRE (>>) |
| FAH → FURIN (>>) |
| FAH → SLC43A1 (>>) |
| FAH → C1orf115 (>>) |
| FAH → MTHFS (>>) |
| FAH → SULT1A1 (>>) |
